CBZ trades 18.2% above Wall Street's consensus target of $44.75.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CBZ achieves its forward estimates and maintains a stable P/E multiple of 13.1x. This scenario reflects the blended consensus of 5 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of October 3, 2026, CBIZ, Inc. (CBZ) has a Wall Street consensus price target of $44.75, based on estimates from 5 covering analysts. With the stock currently trading at $54.69, this represents a potential downside of -18.2%. The company has a market capitalization of $2.93B.
Analyst price targets range from a low of $37.00 to a high of $55.00, representing a 40% spread in expectations. The median target of $43.50 aligns closely with the consensus average.
The current analyst consensus rating is Hold, with 1 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, CBZ trades at a trailing P/E of 29.9x and forward P/E of 13.1x. The forward PEG ratio of 2.45 reflects a premium valuation. Analysts expect EPS to grow +106.6% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $59.76, with bear and bull scenarios of $37.65 and $78.74 respectively. Model confidence stands at 44/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 ESNTEssent Group Ltd. | $5.5B | $60.22 | $70.00 | +16.2% | Buy | 8.0x | 19 |
 KFYKorn Ferry | $3.7B | $71.92 | $85.25 | +18.5% | Buy | 13.5x | 11 |
 HURNHuron Consulting Group Inc. | $2.6B | $162.15 | $176.00 | +8.5% | Buy | 17.6x | 9 |
 FORRForrester Research, Inc. | $218M | $11.22 | — | — | Hold | 14.5x | 4 |
 CASSCass Information Systems, Inc. | $696M | $54.06 | $58.50 | +8.2% | Buy | 18.1x | 2 |
 BAHBooz Allen Hamilton Holding Corporation | $8.1B | $67.35 | $89.00 | +32.1% | Buy | 11.1x | 22 |
 VRSKVerisk Analytics, Inc. | $21.3B | $163.88 | $225.43 | +37.6% | Hold | 21.3x | 25 |
 RHIRobert Half Inc. | $3.7B | $36.12 | $38.00 | +5.2% | Hold | 28.7x | 25 |
 MMSMaximus, Inc. | $2.8B | $52.65 | $110.00 | +108.9% | Buy | 6.6x | 16 |
 ASGNASGN Incorporated | $1.4B | $32.27 | $34.75 | +7.7% | Hold | 8.9x | 13 |
Quick answers to the most common questions about buying CBZ stock.
CBZ's consensus price target is $44.75, -18.2% below the current price of $54.69. The 5 analysts tracking CBZ see downside risk at present valuations.
CBZ has a consensus rating of "Hold" based on 5 Wall Street analysts. The rating breakdown is mixed, with 4 Hold ratings making up the largest segment. The consensus 12-month price target of $44.75 implies -18.2% downside from current levels.
With a forward P/E of 13.1255x, CBZ trades at a relatively low valuation. The consensus target of $44.75 implies -18.2% move, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $55 for CBZ, while the most conservative target is $37. The consensus of $44.75 represents the median expectation. Our quantitative valuation model projects a bull case target of $79 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CBZ is moderately covered, with 5 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 4 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CBZ stock forecast based on 5 Wall Street analysts shows a consensus price target of $44.75, with estimates ranging from $37 (bear case) to $55 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $60, with bear/bull scenarios of $38/$79.
Our quantitative valuation model calculates CBZ's fair value at $60 (base case), with a bear case of $38 and bull case of $79. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 44/100.
CBZ trades at a forward P/E ratio of 13.1x based on next-twelve-months earnings estimates compared to a trailing P/E of 29.9x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on CBZ, with 0 Sell ratings and a price target of $44.75 (-18.2% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CBZ analyst price targets range from $37 to $55, a 40% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $44.75 consensus represents the middle ground. Our model's $38-$79 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.